Valuation: Hofseth BioCare ASA

Market Cap 68Cr 7.33Cr 6.58Cr 6.08Cr 5.51Cr 10Cr 696.53Cr 10Cr 73Cr 29Cr 365.09Cr 28Cr 27Cr 1.16TCr P/E 2024
-5.58x
P/E 2025 -4x
Enterprise Value 98Cr 10Cr 9.4Cr 8.68Cr 7.87Cr 15Cr 994.72Cr 15Cr 104.05Cr 41Cr 521.39Cr 39Cr 38Cr 1.65TCr EV / Sales 2024
3.18x
EV / Sales 2025 3.26x
Free-Float
74.84%
Yield 2024 *
-
Yield 2025 -
1 day-0.38%
1 week-2.24%
Current month-0.76%
1 month-7.09%
6 months-0.76%
Current year-0.76%
1 week 1.26
Extreme 1.265
1.4
1 month 1.25
Extreme 1.25
1.48
Current year 1.1
Extreme 1.1
2.01
1 year 1.1
Extreme 1.1
2.06
3 years 1.1
Extreme 1.1
3.6
5 years 1.1
Extreme 1.1
7.7
10 years 1.1
Extreme 1.1
10.95
Manager TitleAgeSince
Chief Executive Officer 53 01/08/2022
Director of Finance/CFO - 01/09/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 55 01/05/2015
Director/Board Member - -
Director/Board Member - 03/12/2021
Date Insider Type Main position Quantity % Market Cap. Importance
14/07/23 Buy 74,000 0.0187%
28/02/23 Buy

Chief Technology Officer

2,00,000 0.0506%
17/02/23 Buy

Director

1,00,000 0.0253%
Change 5-day change 1-year change 3-year change Capi.($)
-0.38%-2.24%-33.50%-53.21% 7.33Cr
-0.74%-1.10%+4.02%-15.51% 26TCr
-0.98%-2.56%+1.12%-4.09% 7.96TCr
+1.85%+3.19%-19.60%+12.68% 4.42TCr
-1.03%-2.81%+26.25%+11.65% 3.77TCr
-2.21%-2.99%-9.34%-10.65% 3.31TCr
+0.37%-2.82%+21.22%+89.96% 3.09TCr
-1.12%+1.14%-10.93%-7.63% 2.96TCr
-2.71%+0.97%-5.98%-23.47% 2.85TCr
+1.01%+2.92%+5.40%+7.48% 2.74TCr
Average -0.27%-0.31%-2.13%+0.72% 5.69TCr
Weighted average by Cap. -0.46%-0.26%+2.19%-2.81%

Financials

2024 2025
Net sales 27Cr 2.85Cr 2.55Cr 2.36Cr 2.14Cr 4Cr 270.35Cr 4.05Cr 28Cr 11Cr 141.71Cr 11Cr 10Cr 449.37Cr 26Cr 2.75Cr 2.47Cr 2.28Cr 2.06Cr 3.86Cr 260.99Cr 3.91Cr 27Cr 11Cr 136.8Cr 10Cr 10Cr 433.81Cr
Net income -13Cr -1.34Cr -1.21Cr -1.11Cr -1.01Cr -1.89Cr -127.57Cr -1.91Cr -13Cr -5.3Cr -67Cr -5.04Cr -4.93Cr -212.04Cr -13Cr -1.45Cr -1.3Cr -1.2Cr -1.09Cr -2.03Cr -137.33Cr -2.06Cr -14Cr -5.7Cr -72Cr -5.43Cr -5.31Cr -228.26Cr
Net Debt 15Cr 1.56Cr 1.4Cr 1.29Cr 1.17Cr 2.19Cr 147.94Cr 2.21Cr 15Cr 6.15Cr 78Cr 5.85Cr 5.72Cr 245.9Cr 29Cr 3.14Cr 2.82Cr 2.6Cr 2.36Cr 4.41Cr 298.19Cr 4.46Cr 31Cr 12Cr 156.3Cr 12Cr 12Cr 495.65Cr
Projected Income Statement - Annual - Hofseth BioCare ASA
Logo Hofseth BioCare ASA
Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
Employees
81
Date Price Change Volume
27/26/27 NOK 1.310 -0.38% 44,422
26/26/26 NOK 1.315 -1.50% 1,17,785
23/26/23 NOK 1.335 -1.48% 62,248
22/26/22 NOK 1.355 +1.88% 49,626
21/26/21 NOK 1.330 -0.75% 45,556